All‐cause mortality · adults with HIV infection
Multiple micronutrients showed no clear difference in mortality compared with placebo (low certainty).
1 finding from 1 review
Hospital admissions · adults with HIV infection
It is very uncertain whether multiple micronutrients changes hospital admissions compared with placebo (very low certainty).
1 finding from 1 review
CD4 cell count · adults with HIV infection
1 finding from 1 review
Viral load · adults with HIV infection
1 finding from 1 review
Nutritional status · adults with HIV infection
1 finding from 1 review
Weight (kg) · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
Height (cm) · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
Haemoglobin (g/dL) · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
Cognitive function · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
Physical fitness ‐ not measured · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
School attendance · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
School performance · public health programmes to regularly treat all children aged 16 years or less
1 finding from 1 review
Death (between ages 1 and 6 years) · public health programmes to regularly treat all children aged 16 years or less
Multiple doses of deworming drugs showed no clear difference in mortality (between ages 1 and 6 years) compared with placebo (low certainty).
1 finding from 1 review
Parasitological failure At 2 years · patients with treating urinary schistosomiasis
It is very uncertain whether praziquantel 40 mg/kg multiple doses changes parasitological failure At 2 years compared with single dose (very low certainty).
1 finding from 1 review
Mean percent egg reduction At 2 years · patients with treating urinary schistosomiasis
1 finding from 1 review
Parasitological failure At 3 years · patients with treating urinary schistosomiasis
It is very uncertain whether praziquantel 40 mg/kg multiple doses changes parasitological failure At 3 years compared with single dose (very low certainty).
1 finding from 1 review
Adverse events: haematuria 12‐month · patients with treating urinary schistosomiasis
It is very uncertain whether praziquantel 40 mg/kg multiple doses changes haematuria At 3 years compared with single dose (very low certainty).
1 finding from 1 review
Adverse events · patients with treating urinary schistosomiasis
1 finding from 1 review